Skip to main content
. Author manuscript; available in PMC: 2012 Jun 30.
Published in final edited form as: Chem Biol Interact. 2010 Oct 8;192(1-2):122–128. doi: 10.1016/j.cbi.2010.09.032

Figure 2. Inhibition of prostaglandin catalysis by methylglyoxal-modified human serum albumin.

Figure 2

Human serum albumin was modified with MG at various concentrations and 15-keto PGA2 formation was monitored by absorbance at 505 nm. Slope of the initial rate was converted to activity using a molar extinction coefficient of 35,000 M−1 cm−1. Values represent Means ± SE (n=3). Data are statistically significant at the * p<0.05 and *** p<0.001 respectively when compared to control (HSA without MG treatment).